Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes — Stella

Recruiting

Back to Type 2 Diabetes trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Switzerland

Centre Hospitalier Universitaire Vaudois, Lausanne, Canton of Vaud

CHUV, Lausanne

Key details

Sponsor

Heba Al-Alwan

Collaborators

Swiss National Science Foundation, Switzerland, Institute of Primary Health Care (BIHAM), Switzerland

Enrollment target

~76 participants

Started

June 2025

Primary completion

May 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov